Why CONMED Corporation’s (CNMD) Stock Is Up 9.63%
As of Wednesday, November 04, CONMED Corporation’s CNMD share price has surged by 9.63%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Rosalio Madrigal
Jenna Brashear
Rosalio Madrigal
| Share Statistics | CNMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,407.6 | $392.6 | 50% |
|
| Shares Out (Mil) | 30.1 | 40.7 | 37% |
|
| Institutional Ownership | 99.2% | 83.6% | 86% |
|
| Float (Mil) | 29.5 | 35.5 | 35% |
|
| Beta | 0.94 | 0.85 | 56% |
|
| Avg Daily Volume (000s) | 453 | 328 | 57% |
|
| Price Change (52-week) |
7.3% | 63.4% | 57% |
|
| Growth | CNMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 9.8% | 11.8% | 57% |
|
| Net Income (5yr) | 37.7% | (5.5%) | 90% |
|
| EPS (5yr) | 36.4% | 10.6% | 86 |
|
| Dividends (5yr) | (5.6%) | 0.0% | 0% |
|
| Cash Flow (5yr) | 60.3% | (15.6%) | 95% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 7 | |
| Current EPS | $1.265 | $4.573 | $4.749 | |
| Month Ago EPS | $1.266 | $4.536 | $4.782 | |
| # Rev Up | 2 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.266 | $4.536 | $4.782 | |
| Year/Year Chg | 91.7% | 202.8% | 247.0% | |
| Financials | CNMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,369 | $141 | 54% |
|
| Net Income (TTM) (Mil) | $73 | ($9) | 58% |
|
| EPS (TTM) | $2.416 | ($0.400) | 74% |
|
| Operating Cash Flow (TTM) (Mil) | $146 | ($2) | 55% |
|
| Net Cash Flow (TTM) (Mil) | $9 | $1 | 56% |
|
| Long-Term Debt (Q1) (Mil) | $636 | $27 | 61% |
|
| Enterprise Value (Q1) (Mil) | $2,131 | $381 | 50% |
|
| Valuation | CNMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.33 | 2.52 | 37% |
|
| P/E | 19.6 | 28.3 | 52% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.5 | 1.4 | 27% |
|
| Ratios | CNMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.8% | 59.0% | 67% |
|
| Net Margin | 5.4% | (6.6%) | 49% |
|
| ROA | 3.2% | (11.3%) | 62% |
|
| ROE | 7.1% | (10.1%) | 48% |
|
| Liabilities to Assets | 54.0% | 47.1% | 47% |
|
| F-Score | 7 | 4 | 82% |
|
CONMED Corporation did not pass any screens on 11/3/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors